EnCor Breast Biopsy Probe with Rinse Tube— 510(k) K210654

Name: FDA 510(k) clearance K210654
Creator: U.S. Food and Drug Administration
Published: 2021-03-31

Substantially Equivalent

Senorx, Inc.

FDA 510(k) clearance K210654 for EnCor Breast Biopsy Probe with Rinse Tube, Substantially Equivalent on 2021-03-31. Applicant: Senorx, Inc.. Device class: 2.

Clearance details

Applicant: Senorx, Inc.
Product code: Code KNW
Device class: Class 2
Regulation: 21 CFR 876.1075
Advisory panel: Gastroenterology, Urology
Date received: 2021-03-04
Decision date: 2021-03-31
Decision: Substantially Equivalent
Clearance type: Special
Location: Tempe, AZ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KNW

view all

K260517 — Automatic Core Biopsy Instrument2026-08-28
K262571 — EnCor EnCompass Breast Biopsy and Tissue Removal System2026-08-14
K262792 — Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)2026-08-12
K260572 — Marrow Marxman2026-08-04
K261196 — Promisemed VeriEcto Automatic Biopsy Needles2026-05-12

More clearances from Senorx, Inc.

view all

K233220 — EnCor EnspireBreast Biopsy System (E4115, E4230) +4 more2023-10-27
K161805 — EnCor MRI Introducer Set, EnCor Probe Introducer2016-07-19
K131654 — STARCHMARK BREAST TISSUE MARKER; STARCHMARK ULTRACOR BREAST TISSUE MARKER2013-06-27
K093512 — ENCOR BREAST BIOPSY SYSTEM2009-11-20
K092323 — CONTURA CAVITY MAINTENANCE CATHETER2009-08-19

Adverse events under product code KNW

product code KNW

Death: 9
Injury: 965
Malfunction: 10,444
Other: 3
Total: 11,421

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.